Determining the Relationship of Adverse Events to Investigational Products
Determining the Relationship of Adverse Events to Investigational Products Assessing the Relationship Between Adverse Events and Investigational Products Introduction: Why AE–IP Relationship Matters In clinical trials, one of the most important judgments investigators and sponsors make is whether an adverse event (AE) is related to the investigational product (IP). Regulatory authorities such as the FDA,…
Read More “Determining the Relationship of Adverse Events to Investigational Products” »